Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer.
Endocrine polychemotherapy of advanced breast cancer of women was monitored by vaginal hormone receptor cytological examinations and hormone receptor assay. The methods, results and endocrinological observations of the authors have been described. The revision of the indication field of antioestrogen therapy is suggested.
Iglódi
F
F
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000627:therapeutic use*; D008593:Menopause; D013629:Tamoxifen / Q000627:therapeutic use*; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use*; D014626:Vaginal Smears
D000970:Antineoplastic Agents; D006908:Hydroxyprogesterones; D013629:Tamoxifen; D000077713:17 alpha-Hydroxyprogesterone Caproate; D013739:Testosterone